Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics☆
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
Washburn, M. P., Wolters, D., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,752
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
Olsen, J. V., Blagoev, B., Gnad, F., Macek, B., Kumar, C., Mortensen, P., & Mann, M. (2006) · Cell · doi:10.1016/j.cell.2006.09.026 · Cited by 3,499
Glycosylation in Cellular Mechanisms of Health and Disease
Ohtsubo, K., & Marth, J. D. (2006) · Cell · doi:10.1016/j.cell.2006.08.019 · Cited by 2,788
Systematic functional analysis of the yeast genome
Oliver, S. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01214-1 · Cited by 1,302
Acetylation: a regulatory modification to rival phosphorylation?
Kouzarides, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1176 · Cited by 1,160
A new linear ion trap mass spectrometer
Hager, J. W. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.607 · Cited by 479
THE ROLE OF METABOLIC ACTIVATION IN DRUG-INDUCED HEPATOTOXICITY
Park, B. K., Kitteringham, N. R., Maggs, J. L., Pirmohamed, M., & Williams, D. P. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100058 · Cited by 453
Self-citationRole of Metabolism in Drug-Induced Idiosyncratic Hepatotoxicity
Walgren, J. L., Mitchell, M. D., & Thompson, D. C. (2005) · Critical Reviews in Toxicology · doi:10.1080/10408440590935620 · Cited by 322
Analytical strategies for identifying drug metabolites
Prakash, C., Shaffer, C. L., & Nedderman, A. (2007) · Mass Spectrometry Reviews · doi:10.1002/mas.20128 · Cited by 302
Cited by
Protein Analysis by Shotgun/Bottom-up Proteomics
Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., & Yates, J. R. (2013) · Chemical Reviews · doi:10.1021/cr3003533 · Cited by 1,491
Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., & Milgram, E. (2009) · Analytical Chemistry · doi:10.1021/ac901536h · Cited by 1,333
Yuan, M., Breitkopf, S. B., Yang, X., & Asara, J. M. (2012) · Nature Protocols · doi:10.1038/nprot.2012.024 · Cited by 1,117
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
Bantscheff, M., Lemeer, S., Savitski, M. M., & Kuster, B. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6203-4 · Cited by 801
Less label, more free: Approaches in label‐free quantitative mass spectrometry
Neilson, K. A., Ali, N. A., Muralidharan, S., Mirzaei, M., Mariani, M., Assadourian, G., Lee, A., van Sluyter, S. C., & Haynes, P. A. (2011) · PROTEOMICS · doi:10.1002/pmic.201000553 · Cited by 704
Quantitative, High-Resolution Proteomics for Data-Driven Systems Biology
Cox, J., & Mann, M. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061308-093216 · Cited by 685
Decoding signalling networks by mass spectrometry-based proteomics
Choudhary, C., & Mann, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2900 · Cited by 571
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
Maverakis, E., Kim, K., Shimoda, M., Gershwin, M. E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L. R., & Lebrilla, C. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.12.002 · Cited by 459
Liu, X., & Locasale, J. W. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.004 · Cited by 453
Mass spectrometry–based proteomics in cell biology
Walther, T. C., & Mann, M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004052 · Cited by 412
Bridgewater BR, E. A. (2014) · Journal of Postgenomics Drug & Biomarker Development · doi:10.4172/2153-0769.1000132 · Cited by 389
Oligosaccharide Analysis by Mass Spectrometry: A Review of Recent Developments
Kailemia, M. J., Ruhaak, L. R., Lebrilla, C. B., & Amster, I. J. (2014) · Analytical Chemistry · doi:10.1021/ac403969n · Cited by 377
Molecular imaging by mass spectrometry — looking beyond classical histology
Schwamborn, K., & Caprioli, R. M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2917 · Cited by 354
Cholesterol in the retina: The best is yet to come
Pikuleva, I. A., & Curcio, C. A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.03.002 · Cited by 281
Current trends in quantitative proteomics
Elliott, M. H., Smith, D. S., Parker, C. E., & Borchers, C. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1692 · Cited by 271
Zhou, J., & Yin, Y. (2016) · The Analyst · doi:10.1039/c6an01753c · Cited by 245
Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis
Wang, G., Qiu, M., Xing, X., Zhou, J., Yao, H., Li, M., Yin, R., Hou, Y., Li, Y., Pan, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk2756 · Cited by 218
Advantages and Pitfalls of Mass Spectrometry Based Metabolome Profiling in Systems Biology
Aretz, I., & Meierhofer, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050632 · Cited by 167
“The specificity is achieved by fragmenting the analyte and by monitoring both parent and one [44–48] or more product ions simultaneously [49–53].”
BackgroundPhosphosignature predicts dasatinib response in non-small cell lung cancer
Klammer, M., Kaminski, M., Zedler, A., Oppermann, F., Blencke, S., Marx, S., Müller, S., Tebbe, A., Godl, K., & Schaab, C. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.016410 · Cited by 118
Biomarkers intersect with the exposome
Rappaport, S. M. (2012) · Biomarkers · doi:10.3109/1354750x.2012.691553 · Cited by 114
“Figure 2 offers a protocol for conducting EWAS and follow-up studies, which borrows some characteristics from previous work (Hanash et al. 2008; Koulman et al. 2009; Kitteringham et al. 2009; Patel et al. 2010; Zhang et al. 2011).”
Pannee, J., Portelius, E., Oppermann, M., Atkins, A., Hornshaw, M., Zegers, I., Höjrup, P., Minthon, L., Hansson, O., Zetterberg, H., et al. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2012-121471 · Cited by 105
Hu, L., Liu, J., Zhang, W., Wang, T., Zhang, N., Lee, Y. H., & Lu, H. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21611 · Cited by 81
Guo, B., Chen, B., Liu, A., Zhu, W., & Yao, S. (2012) · Current Drug Metabolism · doi:10.2174/138920012803341401 · Cited by 80
Yugandhar, K., Gupta, S., & Yu, H. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.05.007 · Cited by 51
“…[109] Performs better than both “ two-peptide ” and “ one peptide ” rule HIquant [111] Bottom-up approach; requires corresponding ion ratios MRM [115] Requires prior knowledge of all protein stoichiometries/isoforms SWATH MS [116] Saturation of spectral peaks SignalFinder Targeted MS DeconTools…”
BackgroundA site-specific map of the human plasma glycome and its age and gender-associated alterations
Merleev, A. A., Park, D., Xie, Y., Kailemia, M. J., Xu, G., Ruhaak, L. R., Kim, K., Hong, Q., Li, Q., Patel, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73588-x · Cited by 17
Metadata
- Authors
- Kitteringham, N. R., Jenkins, R. E., Lane, C. S., Elliott, V. L., & Park, B. K.
- Venue
- Journal of Chromatography B
- Publisher
- Elsevier BV
- Published
- 2009-05-01
- Volume
- 877
- Issue
- 13
- Pages
- 1229-1239
- ISSN
- 1570-0232 (ISSN-L)
- OpenAlex
- W2113432838
- Cited by
- 343
- References
- 52
- FWCI
- 12.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.